Author： Ulivieri Cristina Baldari Cosima T
Publisher： Informa Healthcare
ISSN： 1476-0584
Source： Expert Review of Vaccines, Vol.12, Iss.3, 2013-03, pp. : 297-310
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tumors as elusive targets of T-cell-based active immunotherapy
By Marincola F.M. Wang E. Herlyn M. Seliger B. Ferrone S.
Trends in Immunology, Vol. 24, Iss. 6, 2003-06 ,pp. :
Access to resources
Recommend
By Holtappels Rafaela Böhm Verena Podlech Jürgen Reddehase Matthias
Medical Microbiology and Immunology, Vol. 197, Iss. 2, 2008-06 ,pp. :
Pathogenic and protective T-cell responses in autoimmune diseases
By Adorini L. Bonneville M. Kollias G.
Research in Immunology, Vol. 149, Iss. 9, 1998-11 ,pp. :
Dendritic cell immunotherapy for autoimmune diabetes
By Feili-Hariri Maryam Flores Rafael Vasquez A. Morel Penelope
Immunologic Research, Vol. 36, Iss. 1-3, 2006-02 ,pp. :
Co-stimulation agonists as a new immunotherapy for autoimmune diseases
By Sun Y. Subudhi S.K. Fu Y.-X.
Trends in Molecular Medicine, Vol. 9, Iss. 11, 2003-11 ,pp. :